The Historical Role and Contemporary Use of Corticosteroids in Inflammatory Bowel Disease

Healthcare Providers Underestimate Patients’ Glucocorticoid Use in Crohn’s Disease

(2019) Subrata Ghosh et al.   DIGESTIVE DISEASES AND SCIENCES

Corticosteroid-Free Remission vs Overall Remission in Clinical Trials of Moderate–Severe Ulcerative Colitis and Crohn’s Disease

(2019) John George et al.   INFLAMMATORY BOWEL DISEASES

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

(2019) Bruce E. Sands et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

(2019) Bruce E. Sands et al.   NEW ENGLAND JOURNAL OF MEDICINE

Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patients

(2019) Christian P. Selinger et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Long-term prognosis of ulcerative colitis and its temporal changes between 1986 and 2015 in a population-based cohort in the Songpa-Kangdong district of Seoul, Korea

(2019) Jae Myung Cha et al.   GUT

Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era—Results from the Dutch Population-Based IBDSL Cohort

(2018) Steven F G Jeuring et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

ACG Clinical Guideline: Management of Crohn’s Disease in Adults

(2018) Gary R Lichtenstein et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study

(2018) Johan Burisch et al.   GUT

Using corticosteroids appropriately in inflammatory bowel disease: a guide for primary care

(2018) Kevin Barrett et al.   BRITISH JOURNAL OF GENERAL PRACTICE

Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort—An Epi-IBD Study

(2018) Johan Burisch et al.   Journal of Crohns & Colitis

Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis

(2017) Raymond K. Cross   INFLAMMATORY BOWEL DISEASES

Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011

(2017) Neeraj Narula et al.   INFLAMMATORY BOWEL DISEASES

DOP060 Real-world treatment pathway visualizations show low use of biologic therapies in Crohn's disease and ulcerative colitis in the United States

(2017) C. Siegel et al.   Journal of Crohns & Colitis

Steroid but not Biological Therapy Elevates the risk of Venous Thromboembolic Events in Inflammatory Bowel Disease: A Meta-Analysis

(2017) Patricia Sarlos et al.   Journal of Crohns & Colitis

Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial

(2017) David T. Rubin et al.   Journal of Crohns & Colitis

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

(2017) Marcus Harbord et al.   Journal of Crohns & Colitis

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders

(2017) Fernando Magro et al.   Journal of Crohns & Colitis

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

(2017) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Steroid dependency and trends in prescribing for inflammatory bowel disease - a 20-year national population-based study

(2016) V. Chhaya et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

(2016) Fernando Gomollón et al.   Journal of Crohns & Colitis

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

(2016) Brian G. Feagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis

(2016) Francesco Manguso et al.   PLoS One

Corticosteroids

(2016) Sivapriya Ramamoorthy et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort

(2016) Akbar K. Waljee et al.   PLoS One

Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies

(2015) W. J. Sandborn et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment of Active Ulcerative Colitis: Results From a Double-Blind, Randomized, Parallel Group Study

(2015) Gert Van Assche et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Prevalence of and Outcomes Associated with Corticosteroid Prescription in Inflammatory Bowel Disease

(2014) Laura E. Targownik et al.   INFLAMMATORY BOWEL DISEASES

Osteonecrosis Following Short-term, Low-dose Oral Corticosteroids: A Population-based Study of 24 Million Patients

(2014) Matthew F. Dilisio   ORTHOPEDICS

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study

(2013) Simon P L Travis et al.   GUT

Infliximab in Steroid-dependent Ulcerative Colitis

(2013) Alessandro Armuzzi et al.   INFLAMMATORY BOWEL DISEASES

Quality Indicators for Inflammatory Bowel Disease

(2013) Gil Y. Melmed et al.   INFLAMMATORY BOWEL DISEASES

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

(2013) Brian G. Feagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

(2013) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

(2012) Gary R Lichtenstein et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study

(2012) William J. Sandborn et al.   GASTROENTEROLOGY

Are there differences in type, dosage, and method of administration for the systemic steroids in IBD treatment?

(2012) Christopher Teshima et al.   INFLAMMATORY BOWEL DISEASES

The Neuropsychiatric Complications of Glucocorticoid Use: Steroid Psychosis Revisited

(2012) Amelia N. Dubovsky et al.   PSYCHOSOMATICS

Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis

(2011) Alexander C Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Mucosal Healing Predicts Late Outcomes After the First Course of Corticosteroids for Newly Diagnosed Ulcerative Colitis

(2011) Sandro Ardizzone et al.   Clinical Gastroenterology and Hepatology

In the treatment of flares of inflammatory bowel disease, intravenous hydrocortisone causes greater falls in blood potassium and more severe episodes of hypokalaemia than methylprednisolone

(2011) A. Wiles et al.   GUT

Guidelines for the management of inflammatory bowel disease in adults

(2011) C. Mowat et al.   GUT

Decision tree for early introduction of rescue therapy in active ulcerative colitis treated with steroids

(2011) Míriam Mañosa et al.   INFLAMMATORY BOWEL DISEASES

Age, Initial Dose and Dose Increase are Independent Risk Factors for Symptomatic Vertebral Fractures in Glucocorticoid-Treated Male Patients

(2011) Takao Sugiyama et al.   INTERNAL MEDICINE

Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study

(2011) T. Shigemura et al.   RHEUMATOLOGY

Review article: what do patients with inflammatory bowel disease want for their clinical management?

(2010) N. WESTWOOD et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis

(2010) Charles N. Bernstein et al.   JOURNAL OF BONE AND MINERAL RESEARCH

3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomised trial

(2010) Volker Gross et al.   Journal of Crohns & Colitis

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preoperative Steroid Use and Risk of Postoperative Complications in Patients With Inflammatory Bowel Disease Undergoing Abdominal Surgery

(2008) Venkataraman Subramanian et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Dose-related patterns of glucocorticoid-induced side effects

(2008) D Huscher et al.   ANNALS OF THE RHEUMATIC DISEASES

The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: A cohort and nested case-control analysis

(2008) Frederick Wolfe et al.   ARTHRITIS AND RHEUMATISM

Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis

(2007) V. F. Panoulas et al.   RHEUMATOLOGY